✦ LIBER ✦

CN3 HEALTH ECONOMIC EVALUATION BASED ON THE 5-YEAR COMPLETED TREATMENT ANALYSIS OF THE ATAC TRIAL COMPARING ANASTROZOLE VERSUS TAMOXIFEN IN ADJUVANT TREATMENT OF POSTMENOPAUSAL HORMONE RECEPTOR POSITIVE EARLY BREAST CANCER

✍ Scribed by K Moeremans; L Annemans

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Cost-effectiveness of anastrozole compar

✍ K. MOEREMANS; L. ANNEMANS 📂 Article 📅 2006 🏛 John Wiley and Sons 🌐 English ⚖ 67 KB

Cost-effectiveness analysis of anastrozo

✍ Gershon Y. Locker; Robert Mansel; David Cella; Deborah Dobrez; Sonja Sorensen; S 📂 Article 📅 2007 🏛 Springer US 🌐 English ⚖ 267 KB

PCN19 AUSTRALIAN COST-EFFECTIVENESS ANAL

✍ A Benedict; D Theodoratou; A Maclean; S Norris; S Campbell; P Mernagh 📂 Article 📅 2005 🏛 John Wiley and Sons 🌐 English ⚖ 63 KB

PCN34 COST-EFFECTIVENESS OF ANASTROZOLE

✍ R Brown; A Benedict; R Mansel 📂 Article 📅 2005 🏛 John Wiley and Sons 🌐 English ⚖ 81 KB